Dr. Keren Landman

Keren Landman, Vox's in-house epidemiologist, shares her insights on the official end of the COVID-19 public health emergency in the U.S. She discusses the transition from federal support to insurance-based care, raising concerns about coverage gaps. The conversation delves into lessons learned from the pandemic response, spotlighting both successes and failures. Landman critiques past strategies and highlights the need for better communication in public health messaging as we prepare for future health crises.

Dr. Keren Landman, Vox's in-house epidemiologist, dives into the emergence of the Pirola COVID variant and its implications for public health. She shares insights on the recent surge in cases, particularly affecting children, as schools reopen. The conversation touches on the evolving public attitudes towards health risks and the importance of adaptable strategies for managing safety. Landman also discusses the challenges of tracking new variants and emphasizes the ongoing relevance of vaccination and treatments like Paxlovid in navigating this new landscape.

Dr. Keren Landman, Vox’s in-house epidemiologist, dives into the nuances of the surging BA.5 COVID-19 variant, now the dominant strain in the U.S. She discusses the challenges of vaccinated immunity and the effects of the Paxlovid treatment, including the intriguing phenomenon of Paxlovid rebound. With public apathy on the rise, Dr. Landman emphasizes the importance of personal responsibility in health management, urging listeners to stay informed and proactive in navigating this new DIY era of the pandemic.